Episodes (Page 2)
✨
Compare vasoconstrictors: terlipressin, norepinephrine, midodrine for HRS.
✨
Distinguish HRS-AKI from other AKI causes in cirrhosis.
✨
Rethink fracture risk assessment beyond osteoporosis.
✨
Initiate and safely use medications for orthostatic hypotension.
✨
Counsel patients on non-pharmacologic orthostatic hypotension interventions.
✨
Compare imaging modalities for pneumothorax diagnosis.
✨
Work up neutropenia and identify benign causes.
✨
Reflect on personal stories that impact patient care.
✨
Analyze clinical reasoning and contextual missteps in a case.
✨
Interpret imaging and pleural fluid studies for effusions.
✨
Share raw and real stories from the start of July.
✨
Discussed beta blockers' role post-MI, even with good heart function.
✨
Defined invasive fungal disease and identified high-risk patients.
✨
Contrasted A1c limitations with Continuous Glucose Monitor (CGM) data.
✨
Discussed imaging choices (U/S, CT, MRI) for IR consultations.
✨
Reviewed reversible causes and fiber's role in constipation.
✨
Examined HIV prevention efficacy versus effectiveness.
✨
Explained Lipoprotein(a) (Lp(a)) beyond standard lipid panels.
✨
Introduced a new framework for clots beyond provoked/unprovoked.
#172 Microplastics and Macro CV Health Problems: Beyond Journal Club on APACHe Study with NEJM Group
✨
Investigated microplastics' potential impact on human health.